Viemed Healthcare (NASDAQ:VMD) Announces Earnings Results

Viemed Healthcare (NASDAQ:VMD) released its earnings results on Wednesday. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01), FiscalAI reports. The firm had revenue of $80.67 million for the quarter, compared to analyst estimates of $80.78 million. Viemed Healthcare had a return on equity of 10.77% and a net margin of 5.03%.

Viemed Healthcare Trading Down 10.9%

Viemed Healthcare stock opened at $9.01 on Friday. The business has a 50 day moving average price of $9.26 and a two-hundred day moving average price of $9.59. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. Viemed Healthcare has a 12 month low of $6.05 and a 12 month high of $12.61. The stock has a market cap of $343.17 million, a price-to-earnings ratio of 23.71, a price-to-earnings-growth ratio of 2.45 and a beta of 1.05.

Wall Street Analysts Forecast Growth

VMD has been the subject of several research analyst reports. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 5th. Barrington Research started coverage on Viemed Healthcare in a report on Monday, August 24th. They issued an “outperform” rating and a $14.00 target price on the stock. Wall Street Zen downgraded Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Finally, Weiss Ratings lowered Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Viemed Healthcare has an average rating of “Hold” and an average price target of $14.00.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.